41
Evaluate the Safety, Tolerability and Immunogenicity Study of GLS-5300 in Healthy Volunteers
Condition(s):HealthyLast Updated:May 27, 2020Completed
49 Clinical Trials Sponsored by “Inovio Pharmaceuticals”, Page 5 of 5
Hide Studies Not Open or Pending
42
Phase I, Open Label Dose Ranging Safety Study of GLS-5300 in Healthy Volunteers
Condition(s):HealthyLast Updated:January 9, 2019Completed
43
A Phase II Clinical Trial of Chemo-radiotherapy in Combination With INO-3112 in Patients With Locally Advanced Cervical Cancer
Condition(s):Uterine Cervical NeoplasmsLast Updated:May 13, 2016Withdrawn
44
Safety, Tolerability and Immunogenicity of INO-4800 Followed by Electroporation in Healthy Volunteers for COVID19
Condition(s):Coronavirus Infection; SARS-CoV 2Last Updated:June 25, 2020Not yet recruiting
45
A Study to Test the Tolerability of an Investigational Electroporation Device in Healthy Adults (V930-001)
Condition(s):HealthyLast Updated:August 4, 2015Completed
46
Therapeutic Vaccination in Treated HIV Disease
Condition(s):HIV-1-infectionLast Updated:September 25, 2019Recruiting
47
Platform Study for Prostate Researching Translational Endpoints Correlated to Response to Inform Use of Novel Combinations
Condition(s):Metastatic Castration-resistant Prostate CancerLast Updated:January 31, 2020Recruiting
48
WT1 Immunity Via DNA Fusion Gene Vaccination in Haematological Malignancies by Intramuscular Injection Followed by Intramuscular Electroporation
Condition(s):Leukaemia (Acute); Leukaemia (Chronic); Leukaemia (Acute Myeloid); Leukaemia (Acute Lymphoblastic); Leukaemia (Acute Promyelocytic)Last Updated:September 7, 2018Completed
49
VGX-3100 and Electroporation in Treating Patients With HIV-Positive High-Grade Anal Lesions
Condition(s):Anal Intraepithelial Neoplasia; High Grade Squamous Intraepithelial Neoplasia; HIV Positivity; Human Papillomavirus-16 Positive; Human Papillomavirus-18 PositiveLast Updated:July 10, 2020Recruiting